These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
210 related articles for article (PubMed ID: 31215139)
1. BRD4 inhibitor and histone deacetylase inhibitor synergistically inhibit the proliferation of gallbladder cancer in vitro and in vivo. Liu S; Li F; Pan L; Yang Z; Shu Y; Lv W; Dong P; Gong W Cancer Sci; 2019 Aug; 110(8):2493-2506. PubMed ID: 31215139 [TBL] [Abstract][Full Text] [Related]
2. Anticancer effects of suberoylanilide hydroxamic acid in esophageal squamous cancer cells in vitro and in vivo. Tzao C; Jin JS; Chen BH; Chung HY; Chang CC; Hsu TY; Sun GH Dis Esophagus; 2014; 27(7):693-702. PubMed ID: 24033428 [TBL] [Abstract][Full Text] [Related]
3. The Bromodomain Inhibitor JQ1 and the Histone Deacetylase Inhibitor Panobinostat Synergistically Reduce N-Myc Expression and Induce Anticancer Effects. Shahbazi J; Liu PY; Atmadibrata B; Bradner JE; Marshall GM; Lock RB; Liu T Clin Cancer Res; 2016 May; 22(10):2534-44. PubMed ID: 26733615 [TBL] [Abstract][Full Text] [Related]
4. Liensinine induces gallbladder cancer apoptosis and G2/M arrest by inhibiting ZFX-induced PI3K/AKT pathway. Shen Y; Bian R; Li Y; Gao Y; Liu Y; Xu Y; Song X; Zhang Y Acta Biochim Biophys Sin (Shanghai); 2019 Jun; 51(6):607-614. PubMed ID: 31074773 [TBL] [Abstract][Full Text] [Related]
5. A novel harmine derivative, N-(4-(hydroxycarbamoyl)benzyl)-1-(4- methoxyphenyl)-9H-pyrido[3,4-b]indole-3-carboxamide (HBC), as histone deacetylase inhibitor: in vitro antiproliferation, apoptosis induction, cell cycle arrest, and antimetastatic effects. Miao JF; Peng YF; Chen S; Gao WJ; Yang QX; Zhu P; Guo J; Tao J; Luo L; Zhang Y; Ling Y Eur J Pharmacol; 2018 Apr; 824():78-88. PubMed ID: 29428472 [TBL] [Abstract][Full Text] [Related]
6. Highly active combination of BRD4 antagonist and histone deacetylase inhibitor against human acute myelogenous leukemia cells. Fiskus W; Sharma S; Qi J; Valenta JA; Schaub LJ; Shah B; Peth K; Portier BP; Rodriguez M; Devaraj SG; Zhan M; Sheng J; Iyer SP; Bradner JE; Bhalla KN Mol Cancer Ther; 2014 May; 13(5):1142-54. PubMed ID: 24435446 [TBL] [Abstract][Full Text] [Related]
7. Histone Deacetylase Inhibitors Inhibit the Proliferation of Gallbladder Carcinoma Cells by Suppressing AKT/mTOR Signaling. Zhang P; Guo Z; Wu Y; Hu R; Du J; He X; Jiao X; Zhu X PLoS One; 2015; 10(8):e0136193. PubMed ID: 26287365 [TBL] [Abstract][Full Text] [Related]
8. Histone deacetylase inhibitor (SAHA) and repression of EZH2 synergistically inhibit proliferation of gallbladder carcinoma. Yamaguchi J; Sasaki M; Sato Y; Itatsu K; Harada K; Zen Y; Ikeda H; Nimura Y; Nagino M; Nakanuma Y Cancer Sci; 2010 Feb; 101(2):355-62. PubMed ID: 19860841 [TBL] [Abstract][Full Text] [Related]
9. Antitumor activity of SAHA, a novel histone deacetylase inhibitor, against murine B cell lymphoma A20 cells in vitro and in vivo. Yang B; Yu D; Liu J; Yang K; Wu G; Liu H Tumour Biol; 2015 Jul; 36(7):5051-61. PubMed ID: 25649979 [TBL] [Abstract][Full Text] [Related]
10. Histone Deacetylase (HDAC) Inhibitor, Suberoylanilide Hydroxamic Acid (SAHA), Induces Apoptosis in Prostate Cancer Cell Lines via the Akt/FOXO3a Signaling Pathway. Shi XY; Ding W; Li TQ; Zhang YX; Zhao SC Med Sci Monit; 2017 Dec; 23():5793-5802. PubMed ID: 29211704 [TBL] [Abstract][Full Text] [Related]
11. Downregulation of BRD4 inhibits gallbladder cancer proliferation and metastasis and induces apoptosis via PI3K/AKT pathway. Hao J; Yang Z; Wang L; Zhang Y; Shu Y; Jiang L; Hu Y; Lv W; Dong P; Liu Y Int J Oncol; 2017 Sep; 51(3):823-831. PubMed ID: 28766687 [TBL] [Abstract][Full Text] [Related]
12. Histone deacetylase inhibitors suppress the growth of human osteosarcomas in vitro and in vivo. Wu Z; Ma C; Shan Z; Ju Y; Li S; Zhao Q J BUON; 2013; 18(4):1032-7. PubMed ID: 24344034 [TBL] [Abstract][Full Text] [Related]
13. Anticancer activity of SAHA, a potent histone deacetylase inhibitor, in NCI-H460 human large-cell lung carcinoma cells in vitro and in vivo. Zhao Y; Yu D; Wu H; Liu H; Zhou H; Gu R; Zhang R; Zhang S; Wu G Int J Oncol; 2014 Feb; 44(2):451-8. PubMed ID: 24297449 [TBL] [Abstract][Full Text] [Related]
14. Single Agent and Synergistic Activity of the "First-in-Class" Dual PI3K/BRD4 Inhibitor SF1126 with Sorafenib in Hepatocellular Carcinoma. Singh AR; Joshi S; Burgoyne AM; Sicklick JK; Ikeda S; Kono Y; Garlich JR; Morales GA; Durden DL Mol Cancer Ther; 2016 Nov; 15(11):2553-2562. PubMed ID: 27496136 [TBL] [Abstract][Full Text] [Related]
15. Anticancer effects of the MHY218 novel hydroxamic acid-derived histone deacetylase inhibitor in human ovarian cancer cells. Jeon HS; Ahn MY; Park JH; Kim TH; Chun P; Kim WH; Kim J; Moon HR; Jung JH; Kim HS Int J Oncol; 2010 Aug; 37(2):419-28. PubMed ID: 20596669 [TBL] [Abstract][Full Text] [Related]
16. Enhancement of BDNF Expression and Memory by HDAC Inhibition Requires BET Bromodomain Reader Proteins. Sartor GC; Malvezzi AM; Kumar A; Andrade NS; Wiedner HJ; Vilca SJ; Janczura KJ; Bagheri A; Al-Ali H; Powell SK; Brown PT; Volmar CH; Foster TC; Zeier Z; Wahlestedt C J Neurosci; 2019 Jan; 39(4):612-626. PubMed ID: 30504275 [TBL] [Abstract][Full Text] [Related]
17. Suberoylanilide hydroxamic acid increases anti-cancer effect of tumor necrosis factor-α through up-regulation of TNF receptor 1 in lung cancer cells. You BR; Han BR; Park WH Oncotarget; 2017 Mar; 8(11):17726-17737. PubMed ID: 28099148 [TBL] [Abstract][Full Text] [Related]
18. S-adenosylmethionine induces apoptosis and cycle arrest of gallbladder carcinoma cells by suppression of JAK2/STAT3 pathways. Liu Y; Bi T; Yuan F; Gao X; Jia G; Tian Z Naunyn Schmiedebergs Arch Pharmacol; 2020 Dec; 393(12):2507-2515. PubMed ID: 32219484 [TBL] [Abstract][Full Text] [Related]
19. Antitumor effects of a novel phenylbutyrate-based histone deacetylase inhibitor, (S)-HDAC-42, in prostate cancer. Kulp SK; Chen CS; Wang DS; Chen CY; Chen CS Clin Cancer Res; 2006 Sep; 12(17):5199-206. PubMed ID: 16951239 [TBL] [Abstract][Full Text] [Related]
20. Synergistic Combination of Histone Deacetylase Inhibitor Suberoylanilide Hydroxamic Acid and Natural Flavonoid Curcumin Exhibits Anticancer and Antibacterial Activity. Altundağ EM; Toprak K; Şanlıtürk G; Güran M; Özbilenler C; Kerküklü NR; Yılmaz AM; Yalçın AS Anticancer Agents Med Chem; 2021; 21(10):1301-1308. PubMed ID: 33023457 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]